Strong Independent Association of TILs with OS for Patients with ERBB2-positive Early Breast Cancer By Ogkologos - February 26, 2025 570 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from updated analysis of the ShortHER study Source RELATED ARTICLESMORE FROM AUTHOR The Legacy of the ESMO Patient Engagement Summit 2025: Advancing Rights of Patients with Cancer via Cross-Border Best Practices and Collaboration Sustained PFS Benefit of Imlunestrant Over SoC in Patients with ESR1-mutated Advanced Breast Cancer ESMO Welcomes Launch of Health Package Introducing EU Measures That Can Boost Innovation in Oncology and Help Prevent New Cancer Cases MOST POPULAR A Rare Childbirth Complication Wiped This Woman’s Memory Of Giving Birth... December 4, 2019 New on NCI’s Websites for June 2023 June 29, 2023 How Can Hormone Replacement Therapy for Menopause Impact My Cancer Risk? January 4, 2023 Bra Straps with Disappearing Message Remind Women to Check Their Breasts... April 12, 2021 Load more HOT NEWS FDA Approves Crizotinib for ALK-positive Inflammatory Myofibroblastic Tumour EMA Recommends Extension of Indications for Tafasitamab Larger NGS Gene Panel Linked to More Clinical Utility Man Born Without Legs Proves He’s Greater Than Any Obstacle He’s...
